Danaher Co. (NYSE:DHR) Shares Sold by Kingswood Wealth Advisors LLC

Kingswood Wealth Advisors LLC lessened its stake in shares of Danaher Co. (NYSE:DHR) by 69.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,410 shares of the conglomerate’s stock after selling 7,729 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in Danaher were worth $783,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of DHR. Decker Retirement Planning Inc. acquired a new position in shares of Danaher during the fourth quarter worth about $31,000. Teachers Insurance & Annuity Association of America acquired a new position in shares of Danaher during the third quarter worth about $39,000. MidAtlantic Capital Management Inc. acquired a new position in shares of Danaher during the third quarter worth about $40,000. FSA Wealth Management LLC acquired a new position in shares of Danaher during the third quarter worth about $50,000. Finally, Darwin Wealth Management LLC acquired a new position in shares of Danaher during the third quarter worth about $55,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of NYSE DHR opened at $247.77 on Wednesday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a 50 day simple moving average of $235.75 and a 200-day simple moving average of $253.65. The company has a market cap of $178.96 billion, a PE ratio of 47.29, a P/E/G ratio of 4.43 and a beta of 0.83. Danaher Co. has a 12-month low of $225.42 and a 12-month high of $281.70.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be given a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. Danaher’s dividend payout ratio is presently 20.61%.

Analyst Upgrades and Downgrades

Several research firms recently commented on DHR. TD Cowen boosted their price target on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Raymond James cut their price target on Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 21st. Guggenheim began coverage on Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target on the stock. Stephens reiterated an “overweight” rating and issued a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. Finally, Robert W. Baird cut their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research note on Tuesday. Six research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $285.81.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.